15 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 13.2% per year over the past 5 years.
Operating margin has contracted, at -2.5% in the latest year.
Free cash flow has declined 10.1% per year over the past 5 years.
Financial health
Total debt ($794M) exceeds cash ($186M); net debt is $608M.
Operating income covered interest expense -0.9× in the latest year.
Total debt is 8.4× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2026
$870M
-$8M
46.9%
-2.5%
-0.4%
-0.2%
$32M
$794M
$186M
2025
$895M
-$1.1B
47.1%
-118.6%
-52.7%
-31.7%
-$46M
$894M
$129M
2024
$924M
-$9M
50.2%
6.3%
-0.3%
-0.2%
-$76M
$891M
$171M
2023
$822M
-$23M
49.4%
4.6%
-0.7%
-0.5%
-$25M
$885M
$163M
2022
$527M
$48M
46.1%
11.1%
5.4%
4.9%
$44M
$0
$44M
2021
$468M
$61M
45.9%
15.8%
7.2%
6.6%
$54M
—
$76M
2020
$418M
$59M
46.9%
16.1%
8.2%
7.5%
$62M
—
$66M
2019
$414M
$60M
46.3%
16.4%
9.4%
8.6%
$49M
—
$42M
2018
$398M
$63M
46.8%
17.6%
11.3%
10.2%
$48M
—
$83M
2017
$358M
$44M
47.1%
18.1%
9.3%
8.3%
$46M
—
$78M
2016
$321M
$37M
47.6%
17.6%
9.0%
8.1%
$21M
—
$55M
2015
—
$34M
—
—
9.6%
8.5%
—
—
$66M
2014
—
$28M
—
—
9.2%
8.2%
$10M
—
$41M
2013
—
$27M
—
—
10.5%
9.4%
$18M
—
$50M
2012
—
$23M
—
—
10.3%
8.9%
$10M
—
$49M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
May '26
$225M
-$11M
47.8%
1.4%
-0.5%
-0.3%
$26M
$794M
$186M
Feb '26
$211M
-$17M
46.9%
-1.6%
-0.8%
-0.5%
$11M
$793M
$160M
Nov '25
$225M
-$16M
47.5%
-2.4%
-0.8%
-0.5%
$8M
$793M
$145M
Aug '25
$209M
$36M
45.4%
-7.7%
1.7%
1.1%
-$13M
$793M
$139M
May '25
$226M
-$612M
41.2%
-271.0%
-29.6%
-17.8%
$300000
$894M
$129M
Feb '25
$221M
-$11M
49.9%
2.4%
-0.4%
-0.3%
-$13M
$891M
$128M
Nov '24
$231M
-$456M
49.0%
-197.8%
-17.1%
-11.3%
$23M
$890M
$140M
Aug '24
$217M
-$13M
48.4%
1.0%
-0.4%
-0.3%
-$56M
$889M
$120M
May '24
$237M
-$5M
47.9%
5.5%
-0.2%
-0.1%
$2M
$891M
$171M
Feb '24
$229M
-$2M
51.1%
5.3%
-0.1%
-0.0%
-$62M
$890M
$161M
Nov '23
$230M
-$3M
50.9%
6.3%
-0.1%
-0.1%
-$9M
$889M
$206M
Aug '23
$229M
$2M
51.0%
8.4%
0.0%
0.0%
-$8M
$889M
$179M
May '23
$242M
$6M
50.9%
9.7%
0.2%
0.1%
$65M
$885M
$163M
Feb '23
$218M
$8M
49.5%
7.2%
0.3%
0.2%
-$32M
$885M
$67M
Nov '22
$230M
-$42M
48.9%
-3.3%
-1.3%
-0.9%
-$31M
$924M
$100M
Aug '22
$132M
$5M
47.0%
4.6%
0.6%
0.5%
-$27M
—
$107M
May '22
$140M
$15M
46.4%
12.9%
1.7%
1.5%
$8M
$0
$44M
Feb '22
$128M
$5M
44.8%
5.0%
0.6%
0.6%
-$65000
—
$43M
Nov '21
$131M
$11M
46.4%
9.6%
1.3%
1.1%
$14M
—
$51M
Aug '21
$128M
$17M
46.8%
16.9%
2.0%
1.8%
$22M
—
$71M
Valuation over time
How the market has priced NEOG against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 83.6× (Mar '23) to 77.7× (Apr '23).
The price-to-sales ratio has fallen from 7.7× (Mar '23) to 2.9× (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is NEOG growing its revenue and profit?
Over the past 5 years, Neogen Corp's revenue has grown 13.2% per year. These are computed facts, not advice.
How much debt does NEOG have?
As of FY2026, Neogen Corp reported $794M of total debt against $186M of cash; operating income covered interest expense -0.9×.
What is NEOG's profit margin?
In FY2026, gross margin was 46.9%, operating margin -2.5%, and net margin -0.9%.
What is NEOG's P/E ratio?
As of Sep '26, Neogen Corp traded at a price-to-earnings ratio of about 77.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.